ATXI Articles, Avenue Therapeutics Inc.

Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...

Avenue Therapeutics (NASDAQ:ATXI) shares are trading lower by 20.7% to $4.92 during Monday’s session after the company announced the exercise...

Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results. ...

U.S. stocks traded slightly lower toward the end of trading, with the S&P 500 edging lower on Wednesday. The Dow traded down 0.18% to 38,434.99...

U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Wednesday. The Dow traded down 0.33% to 38,376.53 wh...

Avenue Therapeutics Inc (NASDAQ:ATXI) shares are trading lower by 28.5% to $0.09 during Wednesday’s session after the company announced a rev...

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Wednesday. Following the market opening Wednesday, the Dow ...

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical compan...

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated ap...

Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic ...